TQB3006
/ Sino Biopharm
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
May 22, 2025
TQB3006-I-01: A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant Cancer
(clinicaltrials.gov)
- P1 | N=27 | Completed | Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Recruiting ➔ Completed | N=112 ➔ 27 | Trial completion date: Aug 2026 ➔ May 2025
Enrollment change • Trial completion • Trial completion date • Oncology
April 26, 2024
A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant Cancer
(clinicaltrials.gov)
- P1 | N=93 | Recruiting | Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Metastases • Oncology
April 03, 2024
A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant Cancer
(clinicaltrials.gov)
- P1 | N=93 | Not yet recruiting | Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
New P1 trial • Oncology
1 to 3
Of
3
Go to page
1